ArticleBiochemical pharmacology2010

Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance.

Ye-Hong Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.